Lv2
198 积分 2024-11-20 加入
Setidegrasib in Advanced Non–Small-Cell Lung Cancer and Pancreatic Cancer
12天前
已完结
The evolving landscape of CDK2 inhibition in cancer: Therapeutic potential, clinical progress, and future directions
2个月前
已完结
The evolving landscape of CDK inhibitor use in breast cancer therapy and beyond
2个月前
已完结
Safety and efficacy of pembrolizumab, radiation therapy, and surgery versus radiation therapy and surgery for stage III soft tissue sarcoma of the extremity (SU2C-SARC032): an open-label, randomised clinical trial
1年前
已完结
Immune checkpoint inhibitors in treatment of soft-tissue sarcoma: A systematic review and meta-analysis
1年前
已完结
Camizestrant, a next-generation oral SERD, versus fulvestrant in post-menopausal women with oestrogen receptor-positive, HER2-negative advanced breast cancer (SERENA-2): a multi-dose, open-label, randomised, phase 2 trial
1年前
已完结
Imlunestrant with or without Abemaciclib in Advanced Breast Cancer
1年前
已完结
Imlunestrant with or without Abemaciclib in Advanced Breast Cancer
1年前
已完结
皖公网安备34019202002308
